NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | - | ₹1,684 Cr | ₹1,524 Cr | ₹1,669 Cr | ₹1,543 Cr |
What is the latest Revenue of NECTAR LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | - |
| Mar2025 | ₹1,684 Cr |
| Mar2024 | ₹1,524 Cr |
| Mar2023 | ₹1,669 Cr |
| Mar2022 | ₹1,543 Cr |
How is Revenue of NECTAR LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | - | -100.00 | |
| Mar2025 | ₹1,684 Cr | 10.53 | |
| Mar2024 | ₹1,524 Cr | -8.70 | |
| Mar2023 | ₹1,669 Cr | 8.13 | |
| Mar2022 | ₹1,543 Cr | - | |
Compare Revenue of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹206.0 Cr | 2.4% | -13.3% | -23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 2.4% |
-13.3% |
-23.9% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses